About Si-Bone
Si-Bone is a publicly listed company based in San Jose (United States) founded in 2008. Minimally invasive titanium implants for sacroiliac joint disorders are developed. Si-Bone has raised $102.52 million across 7 funding rounds from investors including SVB, Orbimed and Oxford Finance. The company has 344 employees. Its website si-bone.com draws about 36 thousand monthly visits. Si-Bone offers products and services including iFuse Implant System, iFuse 3D, and iFuse TORQ. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is SI-BONE, INC. Its competitors include Nevro, ATEC Spine and Vertos Medical; 2 of its 3 listed competitors have raised funding.
Company details
SI-BONE was founded in 2008 in San Jose, United States, and is engaged in the medical device sector for orthopedic treatments. The iFuse Implant System is provided as a titanium-based solution for minimally invasive sacroiliac joint fusion surgeries. A directory of physicians qualified to perform these procedures is maintained. Operations center on addressing SI joint disorders through innovative fixation technologies.
- Headquarters San Jose, United States
- Employees 344
- Stage Public
- SectorsHealthcare
- Website si-bone.com
- Social LinkedIn X Facebook
- Legal Name Si-Bone, Inc.
- Annual Revenue$167.18 M (USD)28as on Dec 31, 2024
- Net Profit$1.9 M (USD)104as on Dec 31, 2024
- EBITDA-$35.25 M (USD)25as on Dec 31, 2024
- Total Equity Funding$102.52M (USD)
in 7 rounds
- Latest Funding Round$20M (USD), Series D
Jun 2016
- InvestorsSVB
& 7 more
- Employee Count344
Products & Services of Si-Bone
Si-Bone offers a comprehensive portfolio of products and services, including iFuse Implant System, iFuse 3D, and iFuse TORQ.
Device for stabilizing and fusing the sacroiliac joint
Advanced implant for SI joint dysfunction treatment
Implant system for pelvic trauma and fixation
Funding Insights of Si-Bone
Si-Bone has successfully raised a total of $102.52M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $20 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $102.52M
- Total Rounds 7
- Last Round Series D — $20M
- First Round $1.52M
(Mar 2009)
- Investors Count 8
All 7 funding rounds of Si-Bone with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2016 | $20M | Series D | – | Arboretum Ventures | – |
| Nov 2015 | $39.2M | Debt – Conventional | – | – | |
| May 2015 | $21M | Series D | – | – | |
| Apr 2014 | $33M | Series C | – | – | |
| Sep 2011 | $16M | Series B | – | – | |
| Aug 2010 | $11M | Series A | – | Skyline Ventures | – |
| Mar 2009 | $1.52M | Seed | – | – | – |
8 investors in total: 8 institutional.
Investors in Si-Bone
Si-Bone has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Orbimed and Oxford Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare venture capital investments are made by Arboretum Ventures. | arboretumvc.com | Ann Arbor, United States | ||
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
Growth-stage tech investments are made in North America, Europe, Israel. | redline-capital.com | Luxembourg, Luxembourg | ||
US life sciences companies are invested in by Skyline Ventures. | skylineventures.com | Palo Alto, United States | ||
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Growth capital investments are made in healthcare and fintech companies. | mepvc.com | San Francisco, United States | ||
Private equity and venture capital fund focused on the healthcare sector | novoholdings.dk | Hellerup, Denmark | ||
Banking services are provided to innovative companies, investors, and individuals. | 1983 | svb.com | Santa Clara, United States |
Investor details for Si-Bone
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Si-Bone
24 people are tracked at Si-Bone (14 in leadership, 8 in board & advisors, 2 in team); the tracked headcount is 344.
| Name | Role | Group |
|---|---|---|
Laura A. Francis | CEO | Leadership |
Carlton Reckling | Chief Medical Officer & VP, Medical Affairs | Leadership |
Michael Pisetsky | Chief Business & Legal Affairs Officer | Leadership |
Roxanne Simon | VP, Program Management & Quality & Process Improvement | Leadership |
Scott Yerby | SVP, Engineering & CTO | Leadership |
Aimee Einstein | VP of People & Culture | Leadership |
Jeffrey Zigler | VP, Market Access & Reimbursement | Leadership |
Anthony Recupero | President, Commercial Operations | Leadership |
Sarah Duranske | VP, Legal | Leadership |
Neville Lorimer | VP of International | Leadership |
Anshul Maheshwari | CFO | Leadership |
Joyce Goto | VP, Corporate Controller | Leadership |
Troy Wahlenmaier | VP, U.S. Sales | Leadership |
Geoff Maw | VP, US Academic & Commercial Development | Leadership |
Timothy E. Davis, Jr. | Director | Board & advisors |
John G. Freund | Director | Board & advisors |
Jeffrey Dunn | Executive Chairman | Board & advisors |
Gregory K. Hinckley | Director | Board & advisors |
Helen Loh | Director | Board & advisors |
Jeryl Lynn Hilleman | Director | Board & advisors |
4 more people are available in the full profile.
Complete people profiles for Si-Bone
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Si-Bone
Si-Bone is a publicly listed company on the NASDAQ with ticker symbol SIBN in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date17 Oct 2018
- Listed onNASDAQ: SIBN
- Listed entitySI-BONE, Inc.
- Exchange sectorHealth technology
Timeline of Si-Bone
4 dated milestones of Si-Bone across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Si-Bone is founded.
- Funding First funding round of $1.5M.
- Funding Latest funding round, Series D, of $20.0M.
- IPO Lists on the stock exchange (IPO).
Competitors of Si-Bone
Si-Bone has 3 listed competitors in our database, 2 of them funded. They include Nevro, ATEC Spine and Vertos Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nevro.com | 2006 | Menlo Park, United States | $154.1M | 1,215 | Provider of high-frequency spinal cord stimulation implants | |
| atecspine.com | 1990 | San Diego, United States | 839 | Treatment solutions for spine disorders are developed. | ||
| vertosmed.com | 2005 | Aliso Viejo, United States | $177.75M | 140 | Minimally invasive treatments for lumbar spinal stenosis are developed. |
Detailed competitors of Si-Bone
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Si-Bone
The website of Si-Bone (si-bone.com) receives about 36.2K visits a month.
- Monthly visits36.2K
▼ 5% vs previous month
Websites whose visitors overlap most with Si-Bone. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| toi-health.com | 100% | 32K | #991,462 | View details | |
njspinespecialists.net | njspinespecialists.net | 99% | #3,260,149 | – | |
spinalcord.com | spinalcord.com | 96% | #498,197 | – | |
bjdonline.org | bjdonline.org | 95% | – | ||
orlandoortho.com | orlandoortho.com | 91% | #578,291 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Si-Bone
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
3 companies that operate in the same segment as Si-Bone (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Si-Bone
Complete news archive for Si-Bone
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Si-Bone
Si-Bone was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Si-Bone is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Si-Bone is a funded company, having raised a total of $102.52M across 7 funding rounds to date. The company's 1st funding round was a Seed of $1.52M, raised on Mar 2009.
Si-Bone has 344 employees.
Annual revenue of Si-Bone is $167.18M as on Dec 31, 2024.
SI-BONE was founded in 2008 in San Jose, United States, and is engaged in the medical device sector for orthopedic treatments. The iFuse Implant System is provided as a titanium-based solution for minimally invasive sacroiliac joint fusion surgeries. A directory of physicians qualified to perform these procedures is maintained. Operations center on addressing SI joint disorders through innovative fixation technologies.
Si-Bone's top competitors include Nevro, ATEC Spine and Vertos Medical.
Si-Bone offers iFuse Implant System, iFuse 3D, and iFuse TORQ.
Yes, Si-Bone is publicly traded on NASDAQ under the ticker symbol SIBN.
Si-Bone has 8 investors. Key investors include SVB, Orbimed, Oxford Finance, Arboretum Ventures, and Redline Capital Management.
Si-Bone operates through Si-Bone, Inc..